首页> 美国卫生研究院文献>ESMO Open >Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial

【2h】

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial

机译：在以前未经处理的晚期非小细胞肺癌患者中的度量组织口腔血管血管不适合铂化化疗：随机期II速度肺试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To assess the efficacy and safety of a metronomic schedule of oral vinorelbine (mVNR) in advanced non-small-cell lung cancer (NSCLC) in patients unfit for platinum-based combination chemotherapy.

机译：评估口服血红素（MVNR）的疗效和安全性在患者在不合适的基于铂族组合化疗的患者中的口腔血红素肺癌（NSCLC）中的疗效和安全性。

著录项

期刊名称 ESMO Open
作者
A. Camerini; A. Morabito; A. Montanino; R. Bernabé; F. Grossi; R. Ramlau; T.-E. Ciuleanu; G.-L. Ceresoli; G. Pasello; F. de Marinis; J. Bosch-Barrera; P. Laundreau; S. Gautier; C. Ta Thanh Minh; D. Kowalski;
展开▼
作者单位

展开▼
年(卷),期 2021(6),2
年度 2021
页码 100051
总页数 9
原文格式 PDF
正文语种
中图分类
关键词
vinorelbine; carcinoma non-small-cell lung; administration and dosage; randomized controlled trial; frail;

机译：血管内;癌非小细胞肺;给药和剂量;随机对照试验;虚弱;

相似文献

外文文献
中文文献
专利

1. Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial [J] . Platania Marco, Pasini Felice, Porcu Luca, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：口服维护铂金疗疗后高级非小细胞肺癌最佳支持性护理：MA.NI.LA。多中心，随机，控制，第二阶段试验
2. Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group. [J] . Fossella FV, DeVore R, Kerr RN, Journal of Clinical Oncology . 2000,第12期

机译：多西他赛与长春瑞滨或异环磷酰胺在之前接受过含铂化疗方案治疗的晚期非小细胞肺癌患者中的随机III期试验。 TAX 320非小细胞肺癌研究组。
3. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I. [J] . Ramlau R, Zatloukal P, Jassem J, Journal of Clinical Oncology . 2008,第11期

机译：随机比较的III期临床试验，在未接受化疗的晚期或转移性非小细胞肺癌初治患者中比较了贝沙罗汀（L1069-49）/顺铂/长春瑞滨与顺铂/长春瑞滨：SPIRITI。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil (Eicosapentaenoic Acid and Docosahexaenoic Acid) on Lung and Systemic Inflammation in Patients with Acute Lung Injury. [D] . Stapleton, Renee Doney. 2010

机译：鱼油（二十碳五烯酸和二十二碳六烯酸）对急性肺损伤患者的肺和全身炎症的II期，随机，双盲，安慰剂对照试验。
6. Cisplatin-vindesine-mitomycin (MVP) vs cisplatin-ifosfamide-vinorelbine (PIN) vs carboplatin-vinorelbine (CaN) in patients with advanced non-small-cell lung cancer (NSCLC): a FONICAP randomized phase II study. Italian Lung Cancer Task Force (FONICAP). [O] . E. Baldini, C. Tibaldi, A. Ardizzoni, 1998

机译：晚期非小细胞肺癌（NSCLC）患者的顺铂-长春地霉素-丝裂霉素（MVP）与顺铂-异环磷酰胺-长春瑞滨（PIN）与卡铂-长春瑞滨（CaN）：一项FONICAP随机II期研究。意大利肺癌工作组（FONICAP）。
7. Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial [O] . A. Camerini, A. Morabito, A. Montanino, 2021

机译：在以前未经处理的晚期非小细胞肺癌患者中的度量组织口腔血管血管不适合铂化化疗：随机期II速度肺试验结果

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy: results of the randomized phase II Tempo Lung trial

摘要

著录项

相似文献

相关主题

期刊订阅